FDA Pre-Submissions (Q-Submissions) allow you to engage the FDA early, gain critical feedback, and de-risk your regulatory pathway. At Elexes, we help you make the most of this valuable opportunity by preparing persuasive, structured Pre-Sub packages and facilitating productive interactions with the FDA.
Whether you're working on a novel Class II device, SaMD, or PMA product, our team of FDA Pre-Submission consultants guides you from strategy through submission.
Let us help you ask the right questions before it's too late.
FDA Pre-Submissions provide a platform to clarify regulatory expectations prior to submitting your 510(k), De Novo, or PMA application. It is not mandatory but are strongly recommended, especially for complex or novel technologies.
At Elexes, we bring a deep understanding of FDA’s mindset, helping you ask the right questions technical, clinical, or regulatory and document them in an impactful way. We support:
⦿ Meeting requests and briefing packages
⦿ Clarification of testing or clinical study requirements
⦿ Regulatory strategy refinement
⦿ SaMD FDA Pre-Subs and cybersecurity considerations
⦿ Companion diagnostics (CDx) and IVD Pre-Subs
Our Pre-Submission documents align with the latest FDA guidance on Q-Submission Program, ensuring your message is complete, concise, and clear.
⦿ Pre-Sub strategy development tailored to your device type and regulatory path
⦿ Clinical and nonclinical questions framing and justification
⦿ Drafting and formatting of FDA Pre-Submission documents
⦿ Submission to CDRH, CBER, or appropriate FDA office
⦿ Meeting coordination and rehearsal for teleconferences or written feedback
⦿ Post-feedback review and regulatory action planning
This comprehensive approach ensures your FDA Pre-Submission is not only complete but impactful.
Our regulatory experts collaborate with clinical, R&D, and quality teams to craft robust Pre-Submissions across device categories including diagnostics, software, combination products, and implantables.
We don’t just prepare documents, we advise on the optimal timing, questions to ask, and how to phrase them to align with FDA expectations and avoid rejections.
From 510(k) pre-submission to PMA, SaMD to IVDs, we’ve handled Pre-Submissions for diverse technologies, helping clients avoid costly missteps later in development.
Our templates and tools ensure your Pre-Sub packages meet the formatting and content expectations, including RTA checklists outlined by the FDA.
We don’t stop at the meeting. Our team helps you integrate FDA feedback into testing plans, labeling, and final submissions, ensuring a seamless progression to approval.
Make informed decisions with visual clarity. This infographic illustrates how a Pre-Submission fits into your FDA journey and what to expect at each step.
Let Elexes guide your FDA Pre-Submission and help you gain clarity, confidence, and compliance from Day 1.
No, Pre-Submissions (Q-Subs) are not mandatory, but they are highly recommended to clarify regulatory expectations before submitting an application.
Typically, FDA provides feedback within 70 days of receiving a complete Pre-Submission. This timeline may vary based on complexity.
Complex, novel, AI/ML-based or software-based devices benefit the most. It helps clarify testing, clinical, or classification uncertainties early on.
Yes. Our consultants can represent you or support your team during the Pre-Sub meeting with FDA, ensuring alignment and preparedness.
Elexes offers a globally recognized ISO 13485 certification consultant who is renowned to enhancing your business credibility in the medical devices industry.
Our presence across the globe ensures audits are conducted by local-language auditors, facilitating clear communication and understanding.
Our experts provide guidance and consultants to help you adhere to necessary regulations, ensuring your products meet all legal requirements and is compliant to all necessary standards.
At Elexes, we offer to assist in securing additional local certifications, enabling you to manufacture and sell medical devices in various markets across the globe.
We offer complete confidentiality to all our clients which makes us one of the most trusted regulatory and quality compliance consulting.
CEO Masterlink, Arizona
CEO Novasignal, Los Angeles
President ViDava, Florida
Sr. Exe Treedental, Hong Kong
Manager Outset Medical, California
CTO Jana Care, Massachusetts
MD Blackrock Pharma, England
VP Regulatory AliveCor, California
Owner Liz Inc., Arizona
CEO Radformation, New York
Never miss out on any important update on the regulatory & compliance industry across the globe. Subscribe to our newsletter now.
Copyright 2025, Elexes Medical Consulting. All Rights Reserved
Working Hours : Monday to Friday 9:00 AM - 7:00 PM
Team Elexes 
